3Daughters

Executive Summary

3Daughters is a San Francisco-based medical device company dedicated to addressing long-neglected women's health needs, with an initial focus on transforming contraception. The company highlights that 10% of U.S. women of reproductive age use contraception, and of those, 10% use IUDs, a market expected to double by 2032. Critically, 90% of IUD users experience pain during insertion, a problem that 3Daughters aims to solve with bold innovation. The company is currently in Phase 1 development, seeking to commercialize a device that reduces or eliminates insertion pain, potentially expanding IUD adoption and improving patient experience.

Upcoming Catalysts (preview)

• Q2 2026Completion of Phase 1 clinical study and data readout70% success
• Q4 2026Series A funding round to support pivotal trials55% success
• TBDStrategic partnership with a women's health organization for distribution40% success